Trial intelligence / Profile preview

Lactase Enzyme Supplements for Feeding Intolerance in Preterm Neonates

NCT07088302Recruiting

Sponsor
Alexandria University
Start
Aug 2025
Primary completion
Feb 2026
Modality
Replacement Enzymes
Countries
1
01

Overview

Randomised trial of lactase in feeding intolerance (2 arms), sponsored by Alexandria University. Primary endpoint: Feeding intolerance at 2 weeks. Started Aug 2025; status: recruiting.

02

Drugs

lactase
03

Conditions

feeding intolerance

Beyond the preview

Go deeper on NCT07088302.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07088302.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call